Clinical trial
A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
NCT00231829 · Mark H. Einstein, Other · Terminated
Key facts
| NCT number | NCT00231829 |
|---|---|
| Title | A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers |
| Official title | A Pilot Phase II Trial of Celecoxib in Patients With Grade 2 or 3 Endometrioid-type, Clear Cell, and Papillary Serous Uterine Cancers |
| Lead sponsor | Mark H. Einstein, Other |
| Collaborators | Pharmacia Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Uterine Cancer |
| Intervention type | Drug |
| Interventions | Celecoxib |
| Enrollment | 23 |
| Start date | Apr 1, 2003 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | Oct 4, 2005 |
| Last update posted | Apr 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: